Cooperative Agreement SSJTIP18CA0014

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $10,151,871 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the University of California, San Francisco (UCSF) to lead the Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE) consortium. This 4-year award, effective September 30, 2024, aims to promote sustainable, data-driven, and equitable HIV/AIDS programs in Kenya, Uganda,...

This Cooperative Agreement, awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), provides $11,097,080 to Global Health Systems Solutions (GHSS) to build laboratory capacity and improve quality of HIV testing services in the Democratic Republic of the Congo (DRC). The key objectives are to: 1) scale up quality assurance and improvement for HIV rapid testing and TB testing; 2) increase coverage and timeliness of viral load, early...

This $31,206,381 Cooperative Agreement was awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) grant program. The objective is to increase the adoption and sustained practice of priority behaviors and the development and maintenance of enabling social norms, including gender norms, for improved health and development outcomes. This will be achieved through the increased implementation of theory-informed,...

The Center for Advancing Innovation, Inc. was awarded a $2.49 million project grant from the Department of Commerce Economic Development Administration under the BUILD TO SCALE federal grant program (CFDA 11.024) to launch the Global Health Innovation Challenge. Over three years, the Center will source and launch over 60 high-growth startups in the Washington D.C. metro area to address global health threats using technology. The startups will focus on preventing, diagnosing, treating and...

The Centers for Disease Control and Prevention (CDC) awarded a $3,710,204 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to Humana People To People Congo (HPP-Congo), a non-profit organization based in the Democratic Republic of the Congo (DRC). The award, titled "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA", will fund a 5-year project (2024-2029) to strengthen HIV/TB prevention, detection, and treatment services in Kinshasa Province, DRC. Key objectives include...

The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $25,300,000 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to Ciheb Initiative LIMITED in Malawi. The award, titled "ACCELERATING MALAWI'S PEPFAR LABORATORY LOGISTICS AND INFRASTRUCTURE FOR QUALITY 2.0 (AMPLIFY 2.0)", will support comprehensive efforts to combat HIV/AIDS in Malawi through the President's Emergency Plan for AIDS Relief (PEPFAR). The 5-year...

This $3,371,050 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program aims to strengthen the delivery of quality and equitable public health services for HIV prevention, testing, care, and treatment in Jamaica and Trinidad and Tobago. The award, with a performance period from September 2024 to September 2029, is granted to the Caribbean Vulnerable Communities (CVC) and the University of the West Indies Centre for...

This $587,500 Cooperative Agreement award from the Centers for Disease Control and Prevention's (CDC) Global AIDS Program (CFDA 93.067) supports efforts by the Cameroon Baptist Convention Health Board to strengthen public health laboratory systems in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) program. The award period runs from October 2024 through September 2027. Key activities include implementing comprehensive HIV services, strengthening laboratory...

The Centers for Disease Control and Prevention (CDC) awarded a $42,680,510 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to Shwari Health Association, a Cameroon-based non-profit organization, in partnership with Georgetown University's Center for Global Health Practice and Impact and other local entities. The purpose of the "SUSTAIN ADVANCED FACILITY AND COMMUNITY-BASED HIV CASCADE ACTIVITIES IN CAMEROON (SAFECARE-CAMEROON)" project is to develop, implement, and...

The Centers for Disease Control and Prevention (CDC) awarded a $9,250,000 Cooperative Agreement under the Global AIDS federal grant program (CFDA 93.067) to Georgetown University (GU) and 12 Haitian indigenous partners for the "Translating Data and Evidence into Impact Plus (TIDE+)" project. The project aims to improve HIV treatment continuity, increase availability of differentiated service delivery models, prevent treatment interruption, empower peer groups of people living with...